IE53466B1 - Improved process for the preparation of 2,4-diamino-5-(3',4',5'-trimethoxy-benzyl)-pyrimidine - Google Patents

Improved process for the preparation of 2,4-diamino-5-(3',4',5'-trimethoxy-benzyl)-pyrimidine

Info

Publication number
IE53466B1
IE53466B1 IE1520/82A IE152082A IE53466B1 IE 53466 B1 IE53466 B1 IE 53466B1 IE 1520/82 A IE1520/82 A IE 1520/82A IE 152082 A IE152082 A IE 152082A IE 53466 B1 IE53466 B1 IE 53466B1
Authority
IE
Ireland
Prior art keywords
general formula
compound
trimethoxy
reacting
guanidine
Prior art date
Application number
IE1520/82A
Other versions
IE821520L (en
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of IE821520L publication Critical patent/IE821520L/en
Publication of IE53466B1 publication Critical patent/IE53466B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Abstract

The invention relates to an improved process for the preparation of 2,4-diamino-5-(3',4',5'-trimethoxy-benzyl)-pyrimidine of the general formula I by reacting a compound of the general formula II (wherein R is an alkyl group having 1-4 carbon atoms) with guanidine, which comprises preparing the said compound of the general formula II by reacting alpha -(3,4,5-trimethoxy-benzal)- beta -methoxy-propionitrile of the formula III with ethylene glycol monoalkylether of the general formula IV HO-CH2-CH2-OR (IV> (wherein R as as stated above) in the presence of an alkali metal alkoxide at a temperature between 60 DEG and 90 DEG and reacting the compound of the general formula II thus obtained - if desired without isolation - with guanidine in the presence of an alkanol having 4-8 carbon atoms. The advantage of the process is that it is economical and can be carried out with high yields even on industrial scale and provides a product of high purity. The compound of the formula I obtained is a known chemotherapeutical drug.

Description

This invention relates to an improved process for ths preparation of 2,4-diamino-5-{3·,4’,5’-trimethoxybsnzyl)-pyrimidine by reacting a compound of the general formula II (wherein R is an alkyl group having 1-4 carbon atoms) with guanidine.
The a/^-diamino-S-iS’ ,4’ ,5’-trimethoxy-benzyl)pyrimidine of the formula I is a well known chemotherapeutical drug (referred to further onas Trimethoprim), Several procedures are known for ths preparation of the compound of the formula I; some of the said processes take place via a-(3,4,5-trimethoxy-benzyl)-fl(substituted)-acrylic-nitriles.
According to Hungarian Patent No. 149,799 3,4,5-trimethoxy-benzaldehyde is condensed with fi-alkoxy-propionitrile. The yield of the condensation reaction is higher than 80 % and the condensation product thus I - 3 obtained consists of about 80 % of oc-(3,4,5-trimethoxybanzal)-fl-alkoxy-propionitrila and 20 % of According to Hungarian patent No. 162,316 the above known process is rendered more economical by condensing 3,4,5-trimethoxy-benzaldehyde with a B-alkoxy-propionitrile, reacting the condensation product thus obtained with an the amine, isomerising'a-(3,4,5-trimethoxy-benzal)-fl-aminopropionitrile derivative thus obtained into the corresponding benzyl derivative and reacting the latter compound with guanidine. The total yield of Trimethoprim related to the 3,4.5-trimethoxy-benzaldehyde starting material is, however, moderate.
According to Hungarian patent No. 174,318 3,4,5-trimethoxy-benzaldehyde is reacted with a B-(2-alkoxyethoxy)-propionitrile. Thus a «-(3,4,5-trimethoxy-benzal)fl-(2-alkoxy-athoxy)-propionitrile of the general formula Ila S3466 is obtained (wherein R is as stated above) with a yield of above 80 %, which is then isolated, thoroughly purified, subjected to isomerisation at 90-95 °C in the presence of a base into the corresponding benzyl isomer of the general formula II which is than reacted with guanidine to give Trimethoprim with a yield of about 80 %. Thus the total yield of the laboratory scale Trimethoprim production is about 64-72 %, Although tha above process is significantly more economical than the previously described methods, the industrial scale use thereof is mat with serious problems. In the reaction of 3,4,5-trimathoxy-benzaldehyde and fl-(2-alkoxy-ethoxy)-propionitrile water is formed which is distilled off at a high temperature of about 120 °C. At this high temperature hydrolyis of the «-(3,4,5-trimethoxy-benzal)-B-(2-alkoxy-ethoxy)-propionitrile with the water being present takes place.
According to our experiments the nitrile group hydrolyses and the corresponding carboxylic acid is formed in an amount of some per cents. This side reaction gives rise to the formation of tarry side products which comes particularly into prominence as the batch size is increased. Thus the laboratory scale total yield of 64-72 % decreases to about 50-55 % already when - 5 the batch size is of about a 10 molar amount. It can be stated that the above known process is unsatisfactory from economic point of view.
The aim of the present invention is the elaboration 5 of an economical industrial scale process for the preparation of 2,4-diamino-5-(3’,4',5’-trimethoxy-benzyl)-pyrimidina.
It has been found that the o-(3,4,5-trimethoxybenzal)-B-methoxy-propionitrile of the formula III (HI) can be trans-etherified into the corresponding benzal 15 isomer of the general formula Ila almost with.quantitative yields by reacting with an ethylene glycol monoalkyl-ether of the general formula IV ho-ch2-ch2-or (IV) (wherein R is as stated above) and the compound of the general formula Ila can be converted easily into the corresponding benzyl isomer of the general formula II almost by theoretical yields. The benzyl isomer of the general formula II is so pure that it can be reacted without isolation and purification with guanidine to give Trimethoprim.
According to the present invention there is provided a process for the preparation of 2,4-diamino-5-{3’,4’,5’53466 - 6 trimethoxy-benzyl)~pyrimidine of the general formula I by reacting a compound of the general formula II (wherein R is an alkyl group having 1-4 carbon atoms)'with guanidine, which comprises preparing the said compound of the general formula II by reacting «-(3,4,5-trimethoxybenzal)-B-methoxy-propionitiMle . of the formula III with an ethylene glycole monoalkylather of the general formula IV (wherein R is as stated above) in the presence of an alkali alkoxide at a temperature between 60 °C and 90 °C and reacting the compound of the general formula II thus, obtained - if desired without isolation - with guanidine in the presence of an alkanol having 4-8 carbon atoms.
As compound of the general formula IV preferably ethylene glycol monomethylether can be used. The compound of the general formula IV is preferably used in an excess and plays the role of the solvent,too.
As alkali alkoxide preferably sodium methylate can be used.
It is not necessary to isolate the benzal isomer of the general formula Ila obtained in the reaction of the oc-(3,4,5-trimethoxy-benzal)-D-methoxy-propionitrile of the formula III and the ethylene glycol monoalkylether of the general formula IV. Under the reaction conditions used at 60-90 °C - preferably at 80-90 °C - the benzyl isomer is quantitatively formed within a few hours. The benzyl isomer of the general formula II can be isolated or, if desired, reacted with guanidine without isolation.
The benzyl isomer of the general formula II is - 7 reacted with guanidine in the presence of an alcohol having 4-8 carbon atoms. For this purpose preferably tertiary butanol or isobutanol can ba used. The reaction between the benzyl isomer and guanidine can be carried out in the presence of a further organic solvent (a.g. an other alcohol, such as methanol) in addition to the alcohol having 4-8 carbon atoms.
If according to a preferred embodiment of the process of the present invention the compound of the general formula II is reacted with guanidine without isolation, the ethyleneglycol monomethyl ether of the general formula IV is always present in the ring closure stage of the reaction, provided it was used in an excess in the preparation of the benzyl derivative.
It is preferred to add guanidine in the form of an acid addition salt - e.g. the hydrochloride - to the benzyl derivative and to sat free the guanidine from its acid addition salt in the reaction mixture with the aid of a base, preferably an alkali alkoxide.
The reaction of the benzyl isomer and guanidine is carried out preferably at 70-100 °C, advantageously at the boiling point of the reaction mixture.
The «-(3,4,5-trimethoxy-benzal)-B-methoxy-propionitrile of the formula III is prepared in a known manner by reacting 3,4,5-trimethoxy-banzaldehyda with B-methoxypropionitrila. The latter B-methoxy-propionitrile is prepared by reacting acrylic nitrile with methanol in alkaline medium. - 8 The process of the present invention enables the economical industrial scale manufacture of Trimethoprim.
The drawbacks of the process according to Hungarian patent No. 174,318 are eliminated.
The total yield related to 3,4,5-trimethoxy-benzaldehyde is about 80 %. According to the process of the present invention Trimethoprim can be manufactured from tho compound of the formula XII by a one-step technology. The purity of the product obtained meets the therapeutical requirements.
Further details of the present invention are to be found in the Examples without limiting our invention to the said Examples.
Example 1 Preparation of the starting material 1,75 g. of potassium hydroxide are dissolved in 115 ml of methanol. To the solution 55 g of acrylic nitrile are added within 20 minutes at a temperature below 40 °C.
The mixture is stirred at 40 °C for an hour, whereupon 100 g. of 3,4,5-trimethoxy-benzaldehyde are added. Tha reaction mixture is stirred at 60 °C for 8 hours whereupon it is cooled to 30 °C, 55 ml of methanol and in portions 30 g. of potassium hydroxide are added. The suspension formed is stirred for 5 hours, cooled to 20 °C and 500 ml of water are added within 15 minutes. The product is crystallized at 5-10 °C, filtered, washed three times with 15 ml. of methanol and three times with 100 ml. of water -9-. each and dried. Thus 116 g. of o-(3,4,5-trimethoxybenzal)-B-methoxy-propionitrile are obtained, Mp.: 81-83 °C. Yield: 86 %.
Example 2 Preparation of 2f4-diamino-5-(3,,4,,5,-trimethoxybenzyl)-pyrimidine A mixture of 100 g, of oc-(3,4,5-trimethoxy-benzal)-Bmethoxy-propionitrile, 100 ml. of anhydrous ethylene glycol monomethylether and 5 g. of sodium methoxide is stirred at 82-84 °C for 3 hours. The reaction mixture is cooled then to 30 °C,/160 ml. of isobutanol, 40 ml. of methanol, g. of guanidine-hydrochloride and 50 g, of powdered sodium methoxide are added. The reaction mixture is stirred at 35-40 °C for an hour and at 90-92 °C for 7 hours. The crystal suspension is cooled to 20 °C, filtered and washed on the filter three times with 20 ml. of methanol each. The moist substance thus obtained is washed with 500 ml. of lukewarm water (30-35 °C) and dried. Thus 102.5 g. of the title compound are obtained, yield: 93.6 %, mp.: 198-201 °C.

Claims (3)

1. What we claim is: 1.Animproved process for the preparation of 2,4diamino-5-(3’,4’,5’-trimethoxy-benzyl)-pyrimidine of the general formula 1 by reacting a compound of the general formula II 15 (wherein R is an alkyl group having 1-4 carbon atoms) with guanidine, which comprises preparing,the said compound of the general formula II by reacting a-(3,4,5-trimethoxybenz»l)-fi-msthoxy-propionitrile of the formula III (III) with an athylena glycol monoalkylether of the general 25 formula IV ho-ch 2 -ch 2 -or (IV) (wherein R is as stated above) in the presence of an - 11 alkali alkoxide at a temperature between 60 °C and 90 °C and reacting the compound of the general formula II thus obtained - if desired without isolation - with guanidine in the presence of an alkanol having 4-8 carbon atoms.
2. ,A process according to claim 1, which comprises carrying out the reaction of the compounds of the formulae III (III) and IV ho-ch 2 -ch 2 -or (IV) at a temparature between 80 °C end 90 °C.
3.A process according to claim 1, which comprises using sodium methoxide ss alkali alkoxide.
IE1520/82A 1981-06-26 1982-06-25 Improved process for the preparation of 2,4-diamino-5-(3',4',5'-trimethoxy-benzyl)-pyrimidine IE53466B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU811869A HU187370B (en) 1981-06-26 1981-06-26 Improved process for producing 2,4-diamino-5-bracket-3-comma above, 4-comma above,5-comma above-trimethoxy-benzyl-bracket closed-pyrimidine

Publications (2)

Publication Number Publication Date
IE821520L IE821520L (en) 1982-12-26
IE53466B1 true IE53466B1 (en) 1988-11-23

Family

ID=10956594

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1520/82A IE53466B1 (en) 1981-06-26 1982-06-25 Improved process for the preparation of 2,4-diamino-5-(3',4',5'-trimethoxy-benzyl)-pyrimidine

Country Status (21)

Country Link
JP (1) JPS5838266A (en)
AT (1) AT387961B (en)
AU (1) AU547823B2 (en)
BE (1) BE893611A (en)
CA (1) CA1174679A (en)
CH (1) CH648834A5 (en)
CS (1) CS244908B2 (en)
DD (1) DD202703A5 (en)
DK (1) DK155434C (en)
ES (1) ES513482A0 (en)
FI (1) FI76790C (en)
FR (1) FR2508450B1 (en)
GB (1) GB2104508B (en)
GR (1) GR76159B (en)
HU (1) HU187370B (en)
IE (1) IE53466B1 (en)
IL (1) IL66132A (en)
IT (1) IT1190889B (en)
SE (1) SE451133B (en)
SU (1) SU1145929A3 (en)
YU (1) YU42774B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602507B1 (en) * 1986-08-08 1989-06-09 Sanofi Pharma PROCESS FOR THE PREPARATION OF 2,4-DIAMINO-BENZYL-5 PYRIMIDINES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB743221A (en) * 1953-05-26 1956-01-11 Wellcome Found Improvements in or relating to the manufacture of acrylonitriles
DE1303727B (en) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-arylidene-substituted propioni-iriles
NL122146C (en) * 1960-09-02
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
DE2635765C3 (en) * 1976-08-09 1979-02-08 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Process for the preparation of 2,4-EMamino-5- (3 ', 4'r5'-trimethoxybenzyl) -pyrimidine
US4115650A (en) * 1976-11-17 1978-09-19 Hoffmann-La Roche Inc. Process for preparing 2,4-diamino-5-(substituted benzyl)-pyrimidines
DE2730467A1 (en) * 1977-07-06 1979-01-18 Basf Ag BENZYLPYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THE SAME

Also Published As

Publication number Publication date
IT1190889B (en) 1988-02-24
CA1174679A (en) 1984-09-18
AT387961B (en) 1989-04-10
IE821520L (en) 1982-12-26
JPS5838266A (en) 1983-03-05
IL66132A (en) 1985-04-30
SE8203914L (en) 1982-12-27
CS471782A2 (en) 1985-09-17
GB2104508B (en) 1985-01-16
SE8203914D0 (en) 1982-06-23
CH648834A5 (en) 1985-04-15
FI822268A0 (en) 1982-06-24
ES8304949A1 (en) 1983-04-01
SU1145929A3 (en) 1985-03-15
SE451133B (en) 1987-09-07
DK155434B (en) 1989-04-10
IT8222035A0 (en) 1982-06-24
FI76790B (en) 1988-08-31
ATA244982A (en) 1988-09-15
FR2508450A1 (en) 1982-12-31
CS244908B2 (en) 1986-08-14
AU547823B2 (en) 1985-11-07
FR2508450B1 (en) 1986-01-03
HU187370B (en) 1985-12-28
AU8534682A (en) 1983-01-06
DK155434C (en) 1989-09-18
FI76790C (en) 1988-12-12
DD202703A5 (en) 1983-09-28
ES513482A0 (en) 1983-04-01
GR76159B (en) 1984-08-03
YU42774B (en) 1988-12-31
DK288082A (en) 1982-12-27
FI822268L (en) 1982-12-27
YU138582A (en) 1984-10-31
GB2104508A (en) 1983-03-09
BE893611A (en) 1982-12-23
IL66132A0 (en) 1982-09-30

Similar Documents

Publication Publication Date Title
US5225585A (en) Production of fluoxetine and new intermediates
US4977264A (en) Process for the production of 4,5-dichloro-6-ethylpyrimidine
US20090018337A1 (en) Process for the preparation of a pharmaceutical intermediate
US7553978B2 (en) Process for the preparation of 1-naphthol mixed ethers and intermediates of crystalline forms of (+) and (−)-duloxetine
US3855265A (en) 5-benzyl pyrimidines intermediates therefore, and method
CA1235430A (en) Process for the preparation of basically substituted phenylacetonitriles
IE53466B1 (en) Improved process for the preparation of 2,4-diamino-5-(3',4',5'-trimethoxy-benzyl)-pyrimidine
US4143227A (en) Process for substituted 5-benzyl-2,4-diamino-pyrimidines
JP3252502B2 (en) N-5 protected 2,5-diamino-4,6-dichloropyrimidine and method for producing the same
US4255574A (en) Process for preparing 2,4-diamino-pyrimidines
HUT73357A (en) Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidine derivatives
US3850927A (en) 5-benzyl pyrimidines intermediates therefore,and method
JP3031279B2 (en) Method for producing 2-alkoxy-6- (trifluoromethyl) pyrimidin-4-ol
US4789743A (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines
FI76789B (en) PROCEDURE FOR FRAMSTATION OF 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETOXYBENYL) PYRIMIDINE.
JPH0344360A (en) Substituted 1,3-diaminopropane
GB2134521A (en) Improvements in or relating to the synthesis of nizatidine
FR2511246A1 (en) NOVEL CYCLIC ALPHA-AMINODERIVATES OF 1- (3 ', 4'-METHYLENE-DIOXYPHENYL) ETHANOL AND PROCESS FOR PRODUCING THE SAME
FI77656B (en) PROCEDURE FOR FRAMSTATION OF 2,4-DIAMINO-5- / 3,5-DIMETOXY-4- (2-METHOXYETOXY) -BENYL / -PYRIMIDINE.
JP4572616B2 (en) Process for producing carboxylic acid-4-tetrahydropyranyl ester compound
HU204771B (en) Process for producing anilinofumarates from chloromaleates or chlorofumarates or from their mixture
JPS626706B2 (en)
JPH0343276B2 (en)
LT3919B (en) Process for the preparation of 2,5-dichlorophenol derivatives
JPH04295468A (en) Method of manufacturing piperazinylpyrimidine derivative

Legal Events

Date Code Title Description
MM4A Patent lapsed